Green seaweed is currently underused compared with other major seaweed types. Many scientists have reported applications of the green seaweed Ulva in various fields in recent years, which makes it a candidate for biomass production in industrial biorefineries. Ulva contains a unique polysaccharide called ulvan, which is being considered for medicinal and pharmacological applications. Ulvan is a sulfated polysaccharide including rhamnose and glucuronic acid residues, which has a range of bioactivities, including immunomodulatory, antimicrobial, and anticoagulant properties. The biocompatibility of ulvan makes it a versatile candidate for biomaterial design. This review presents an in-depth analysis of the potential applications of ulvan, starting with extraction methods and structural/biological characterization and moving on to biomaterial design. We also highlight the advantages of ulvan over traditional seaweed polysaccharides such as agar, carrageenan, and alginate.
Ulva lactuca is a green seaweed that has three times faster growth than other types of seaweed and high sulfate polysaccharide content that can be used for biological activities. Deep Eutectic Solvents (DES) emerged as an alternative to extracting ulvan due to its biodegradable, environmentally friendly, and harmless nature. This study aims to determine the type and concentration of DES that can produce the best ulvan extract characteristics based on yield, FTIR, and viscosity analysis as well as moisture and sulfate content tests. The stages of research carried out include preparation and characteristics of raw materials, DES synthesis, extraction, and further analysis and tests. Different types and concentrations of DES affect the results of the analysis. The test results showed the highest ulvan yield found in the 30% choline chloride-urea DES type treatment (KKU30), while the sulfate content and viscosity values were found in the 30% choline chloride-glycerol treatment (KKG30). The ulvan functional group in the 30% choline chloride-glycerol treatment (KKG30) showed absorption band results similar to HCl treatment.
Currently, green seaweed is underutilized compared to other major seaweeds. Among green seaweeds, many scientists have reported the utilization of Ulva in various fields in recent years, which intrigues its potential as the next top candidate for biomass in industrial biorefineries. Ulva has unique polysaccharides called ulvan, which are considered for medicinal and pharmacological applications. Ulvan is a sulfated polysaccharide consisting of rhamnose, glucuronic acid, and sulfated sugar units, which offers a range of bioactive properties, including immunomodulation, antimicrobial activity, anticoagulant, and biocompatibility, making it a versatile candidate for biomaterial design. This review presents an in-depth analysis of the potential route for the application of ulvan, starting from extraction methods, structural and biological characterization to biomaterial design, highlighting its advantages over traditional polysaccharides such as agar, carrageenan, and alginate.